- Home
- RZLT vs STRO Comparison
RZLT vs STRO Comparison
Compare RZLT & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RZLT
- STRO
- Stock Information
- Founded
- RZLT 2010
- STRO 2003
- Country
- RZLT United States
- STRO United States
- Employees
- RZLT 59
- STRO N/A
- Industry
- RZLT Biotechnology: Pharmaceutical Preparations
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RZLT Health Care
- STRO Health Care
- Exchange
- RZLT Nasdaq
- STRO Nasdaq
- Market Cap
- RZLT 292.0M
- STRO 292.6M
- IPO Year
- RZLT N/A
- STRO 2018
- Fundamental
- Price
- RZLT $5.18
- STRO $2.80
- Analyst Decision
- RZLT Strong Buy
- STRO Strong Buy
- Analyst Count
- RZLT 8
- STRO 7
- Target Price
- RZLT $11.63
- STRO $12.14
- AVG Volume (30 Days)
- RZLT 367.2K
- STRO 888.5K
- Earning Date
- RZLT 11-07-2024
- STRO 11-13-2024
- Dividend Yield
- RZLT N/A
- STRO N/A
- EPS Growth
- RZLT N/A
- STRO N/A
- EPS
- RZLT N/A
- STRO N/A
- Revenue
- RZLT N/A
- STRO $160,955,000.00
- Revenue This Year
- RZLT N/A
- STRO N/A
- Revenue Next Year
- RZLT N/A
- STRO N/A
- P/E Ratio
- RZLT N/A
- STRO N/A
- Revenue Growth
- RZLT N/A
- STRO 230.90
- 52 Week Low
- RZLT $0.74
- STRO $2.45
- 52 Week High
- RZLT $6.19
- STRO $6.13
- Technical
- Relative Strength Index (RSI)
- RZLT 50.30
- STRO 39.12
- Support Level
- RZLT $4.70
- STRO $2.55
- Resistance Level
- RZLT $5.14
- STRO $2.76
- Average True Range (ATR)
- RZLT 0.34
- STRO 0.27
- MACD
- RZLT -0.04
- STRO -0.05
- Stochastic Oscillator
- RZLT 37.45
- STRO 18.51
About RZLT Rezolute Inc. (NV)
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.